Researchers at Michigan State University are analyzing big data to determine better research models to fight the spread of breast cancer and test potential drugs.
The researchers performed an integrative analysis of data taken from genomic databases, and found substantial difference between lab-created breast cancer cell lines and actual advanced, or metastatic, breast cancer tumor samples.
Surprisingly, MDA-MB-231—a cancer cell line used in nearly all metastatic breast cancer research—showed little genomic similarity to patient tumor samples.
Said Michigan State researcher Bin Chen, "Our study demonstrates the power of leveraging open data to gain insights on cancer."
From Michigan State University
View Full Article
Abstracts Copyright © 2019 SmithBucklin, Washington, DC, USA
No entries found